Oral Presentation Australasian Diabetes in Pregnancy Society Annual Scientific Meeting 2019

Hypertension in pregnancy is a recognised risk factor for future cardiovascular disease in both mother and offspring.  Hypertensive disorders of pregnancy (HDP) comprise gestational hypertension, pre-eclampsia/eclampsia, chronic hypertension and pre-eclampsia superimposed on chronic hypertension. (#3)

Suet-Wan Choy 1
  1. Austin Health, Heidelberg, Vic, Australia

Maternal outcomes:
Women with a history of HDP are at increased risk of developing premature cardiovascular diseases such as hypertension, stroke and ischaemic heart disease later in life1,2. It is unclear whether pregnancy unmasks their cardiovascular risk, or whether HDP are an index event causing cardiovascular damage given the oft shared cardiovascular risk factors. The underlying pathophysiological mechanism for this association is unknown, though plausibly might relate to endothelial dysfunction and subclinical inflammation or ischaemia that persists for years in both the large vessels and microvasculature after delivery 2,3. Exploration of these potential mechanisms will be discussed briefly.

Offspring outcomes:
The associations between HDP and subsequent cardiovascular disease in the offspring are complex. Recent observational epidemiological studies have demonstrated that maternal hypertensive disorders are associated with an adverse cardio-metabolic risk in adult offspring (including raised body mass index, overweight and obesity and higher blood pressure)4,5. Both pre-eclampsia and gestational hypertension are associated with hypertension and stroke in the adult offspring5.

Postpartum follow up:
There is substantial variation in clinical recommendations and guidelines as to the optimal management of these women postpartum6. There is ongoing need for further research to determine effective and cost-efficient follow-up strategies of these high-risk women. The postpartum period offers an ideal opportunity to improve education, offer lifestyle intervention, make an early diagnosis of chronic hypertension and provide appropriate treatments to prevent and potentially reduce long term cardiovascular risk.

  1. 1. MacDonald SD, Malinowski A, Zhou Q et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156:918-30.
  2. 2. Bellamy, L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
  3. 3. Agatisa PK, Ness RB, Roberts JM et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol 2004; 286:H1389-93.
  4. 4. Rice MM, Landon MB, Varner MW, et al. Pregnancy-Associated Hypertension and Offspring Cardiometabolic Health. Obstetrics and Gynecology 2018; 131:2, 313-321
  5. 5. Thoulass JC et al J Epidemiol Community Health 2016; 70:414-422.
  6. 6. Bro Schmidt G, Christensen M, Knudsen UB. Pre-eclampsia and later cardiovascular disease – What do national guidelines recommend? Pregnancy Hypertension: An International Journal of Women’s Cardiovascular Health 2017; 10: 14-17.